CN205786663U - Double labelling time resolved fluoro-immunoassay test kit based on PG magnetic particle - Google Patents
Double labelling time resolved fluoro-immunoassay test kit based on PG magnetic particle Download PDFInfo
- Publication number
- CN205786663U CN205786663U CN201620422755.5U CN201620422755U CN205786663U CN 205786663 U CN205786663 U CN 205786663U CN 201620422755 U CN201620422755 U CN 201620422755U CN 205786663 U CN205786663 U CN 205786663U
- Authority
- CN
- China
- Prior art keywords
- reagent bottle
- box body
- test kit
- drawer
- fixed plate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Landscapes
- Automatic Analysis And Handling Materials Therefor (AREA)
Abstract
Double labelling time resolved fluoro-immunoassay test kit based on PG magnetic particle described in the utility model, it includes box body, be connected with box body for the lid that box body is closed, the first fixed plate it is provided with bottom box body, it is provided with for the most vertically placing enhancing liquid reagent bottle in described first fixed plate, concentrated cleaning solutions reagent bottle and the first groove of reaction buffer reagent bottle, and for vertically placing the magnetic particle reagent bottle being coated PG monoclonal antibody respectively, the calibration object reagent bottle of PG, second groove of the PGII monoclonal antibody solution reagent bottle of europium labelling PG I monoclonal antibody solution reagent bottle and samarium labelling；The lower section being positioned at described box body 1 inner chamber is provided with drawer 13, is equipped with microwell plate 14 in described drawer 13；The convenient use of this utility model test kit, simple to operate, good stability, and there is higher detection sensitivity and specificity, detection more accurately and reliably, and has reached preferably performance parameter, highly sensitive.
Description
Technical field
This utility model relates to the double labelling time resolved fluoro-immunoassay examination of a kind of pepsinogen (PG) magnetic particle
Agent box, belongs to immune detection analytical technology and field of nano biotechnology
Background technology
Pepsinogen (Pesinogen, PG) is pepsic inactive precursor in gastric juice, and human pepsinogen can divide
It is two kinds of biochemistry pepsinogen group different with immunocompetence feature: pepsinogen Cgene (being called for short PG I) and pepsinogen II
(being called for short PGII), PG I is mainly by chief cell and the mucous neck cell secretion of fundic gland, and major part enters gastral cavity, enters blood on a small quantity
Liquid circulates, and PGII derives from full gastric gland and distal duodenum BrunnerShi gland, and the PGII of gastric mucosa synthesis is about total amount
25%.PGII major part enters digestive tract, enters blood circulation on a small quantity, and therefore PG is referred to as " reflection stomach state and function
Pointer ", the change of its level can directly reflect gastric mucosa and duodenum state and the change of cell quantity.The most clinical
Research is pointed out, PG is relatively big with the dependency of gastric mucosa pathological changes, and mensuration PG content helps and detects duodenal ulcer, atrophic
Gastritis, gastritis, other digestive tract disease such as gastric cancer, need for Clinical detection and health check-up examination, PG detects as Noninvasive side
Method, reduces patient suffering, easy, economical, have generaI investigation and be worth.
The pepsinogen (PG) development course to disease of stomach, typically can be expressed as: superficial gastritis gastric mucosa is rotten
Rotten ulcer atrophic gastritis gastric cancer, and Other diseases has good diagnosis and screening effect.Pepsinogen Cgene/II examines
Test carton, for detecting the content of pepsinogen Cgene/II in serum or blood plasma, has simplicity, quick advantage, it is to avoid
The X-ray infringement to human body and the inconvenience of gastroscope；But pepsinogen Test paper box of the prior art is all single inspection
Survey box, i.e. can only individually pepsinogen I or pepsinogen I I be detected single, and in practical operation, sometimes
Need to detect the pepsinogen I in same sample liquid and II, to obtain the pepsinogen I stomach function regulating in same sample liquid
The ratio of the content of pepsinogen II or other ratio PGI/PGII of the two, if PGI/PGII ratio is less than 6, then atrophic stomach
Scorching and gastric cancer risk increases, and individually detects according to pepsinogen I and pepsinogen II, unavoidable during detection
Having error, if pepsinogen I produces a positive error, pepsinogen I I produces a negative error, is calculating
The situation that error is amplified is there will be, it will cause the detection institute of pepsinogen I and pepsinogen II during PGI/PGII ratio
Obtain ratio and there is error with actual ratio, cause result inaccurate.
For the detection of pepsinogen, the most clinical conventional method includes: Immunoturbidimetry, enzyme connection is exempted from
Epidemic disease method (ELISA), chemoluminescence method (CLIA) and Timed resolved fluoroimmunoassay (TRFIA).Latex strengthens immunity ratio
Turbid method, simple to operate, can be full-automatic, but, its sensitivity is the highest, it is impossible to realize accurate quantification；ELISA method and TRFIA
Although method can accurate quantitative analysis, but operating process is complicated, and is not suitable for single part and small batch detection uses.CLIA method is to enter
Opening reagent is main, and relatively costly, technology maturity is the most weak.
Time-resolved fluoroimmunoassay (TRFIA) be after radioimmunoassay, RIA one of label development new
Milestone, it has also become a analysis means the most promising in biomedical research and clinical ultramicron biochemical investigation.
TRFIA, using rare earth ion as label, has and prepares simple, storage time length, "dead" pollution, standard curve range
Wide, not by the interference of sample natural fluorescence and the advantage such as have wide range of applications.Time resolution Double Labelling Technique is to utilize different group of the lanthanides
Interionic wavelength of fluorescence is different with fluorescence decay time, with two kinds of lanthanide series antibody that labelling is different respectively, detects not
With antigen, the method can save time, saving of labor, province's reagent and sample, have economical and efficiently wait outstanding advantages.It is particularly well-suited to many
The United screening experiment of project and the detection of some precious samples, be the developing direction of labelled immune credit analysis.In lanthanide series
Eu3+ and Sm3+ is commonly used for two lanthanide ions that double labeling is analyzed, and β-NTA chelating agen all can be utilized to dissociate and increase
Hyperfluorescence intensity.The maximum emission wavelength of Eu3+ and Sm3+ is respectively 615nm and 643nm, due to narrowed emission, it is possible to fully divide
Distinguish.And both fluorescence lifetimes difference is notable, respectively 820 μ s and 88 μ s, during detection, interference each other is smaller.TRFIA is
Continue Enzyme-multiplied immune technique and put the emerging technology grown up after immune technology, relative to both Chemiluminescence Immunoassays tools rear
Having high sensitivity, high specific, easy and simple to handle, quick, labelling conjugate is stable, the damage of the most "dead" isotope and pollution
Etc. feature, in clinical detection assays, it is widely popularized use the most in recent years.The time resolution of supporting setting in prior art
The detection kit of fluorescence immunoassay, is all to use the reagent bottle by various reagent bottle, containing antibody and microwell plate simply to receive
The mode received puts it into inside test kit, test kit does not carry out any auxiliary and arranges.But, for above-mentioned detectable
For box, reagent bottle and microwell plate in test kit are susceptible to dislocation in transportation and mutually collide, not only bad for
In test kit, reagent, antibody and microwell plate preserve, and rub or may cause reagent bottle, antibody bottle and micropore in collision process
The shell of plate weares and teares so that reagent bottle produces slight crack or ruptures, and causes the active substance in reagent bottle to trickle to bottle
Outer mix, or in reagent bottle, enter air impact reagent or the quality of antibody, and then make examination in test kit in test kit
Agent, antibody or microwell plate lost efficacy.
To this end, this utility model provides a kind of double labelling time resolved fluoro-immunoassay reagent based on PG magnetic particle
Box, by arranging auxiliary device inside test kit, again receives reagent bottle, contains the reagent bottle of antibody, microwell plate, it is to avoid examination
Reagent bottle in agent box and microwell plate are susceptible to dislocation and mutually collision in transportation so that reagent in test kit,
Antibody is intact, and stability is high, has convenient use, advantage simple to operate simultaneously.
Utility model content
Therefore, the technical problems to be solved in the utility model is to provide a kind of convenient use, simple to operate, good stability
And detection more accurately and reliably, sensitivity and the high double labelling time-resolved fluorescence based on PG magnetic particle of specificity sensitivity exempt from
Epidemic disease assay kit.
To this end, this utility model provides a kind of double labelling time resolved fluoro-immunoassay reagent based on PG magnetic particle
Box, it includes box body, and be connected with described box body is provided with bottom the lid closing described box body, described box body
First fixed plate, described first fixed plate is provided with and is the most vertically placed with enhancing liquid reagent bottle, concentrated cleaning solutions reagent bottle
Multiple first grooves adaptive with the size of reaction buffer reagent bottle, and be the most vertically placed with and be coated PG monoclonal antibody
Magnetic particle reagent bottle, the calibration object reagent bottle of PG, europium labelling PG I monoclonal antibody solution reagent bottle and the PGII monoclonal antibody solution of samarium labelling
Multiple second grooves that the size of reagent bottle is adaptive；The lower section being positioned at described box body inner chamber is provided with drawer, accommodating in described drawer
There is microwell plate.
Described test kit, is provided with the second fixed plate in described drawer, described second fixed plate is provided with horizontal positioned
There is the 3rd groove of described microwell plate.
Described test kit, the arm-tie of described drawer is provided with handle.
Described test kit, the top edge of described arm-tie is connected with described box body by attachment means.
Described test kit, the top edge of the arm-tie of described drawer is contour with described box body, the top of described arm-tie
Edge is rotatably connected to clamp, and described drawer can be fixed on described box body on described box body by described clamp with turn buckle.
Described test kit, described first groove, the second groove arrange along the length direction of described first fixed plate successively
Arrange.
It is respectively equipped with some cooling baths in described test kit, described first fixed plate and described second fixed plate, described
Cooling bath is built-in with ice bag.
Described test kit, described microwell plate is made up of removable ELISA Plate and the enzyme mark strip being placed on it.
Described test kit, described microwell plate is 96 transparent orifice plates.
Described test kit, described microwell plate has Fresco Bag outer package, also sets up inside described Fresco Bag outer package
There is desiccant bag.
Mentioned reagent bottle is commercially available prod, in described reagent bottle contain reaction buffer reagent, concentrated cleaning solutions reagent,
Strengthen liquid reagent, be coated the magnetic particle reagent of PG monoclonal antibody, the calibration object reagent of some PG, europium labelling PG I monoclonal antibody solution
The PGII monoclonal antibody solution reagent of reagent and samarium labelling is commercially available prod, and in this utility model, mentioned reagent is by Jiangsu Province's atom
Institute for Medical Research provides.
This utility model technical scheme compared to existing technology, has the advantage that
(1) double labelling time resolved fluoro-immunoassay test kit based on PG magnetic particle described in the utility model, its
Including box body, be connected with described box body is provided with first bottom the lid closing described box body, described box body
Fixed plate, described first fixed plate is provided with and is the most vertically placed with enhancing liquid reagent bottle, concentrated cleaning solutions reagent bottle and anti-
Answer multiple first grooves that the size of buffering agents bottle is adaptive, and be the most vertically placed with the magnetic being coated PG monoclonal antibody
Microgranule reagent bottle, the calibration object reagent bottle of PG, europium labelling PG I monoclonal antibody solution reagent bottle and the PGII monoclonal antibody solution reagent of samarium labelling
Multiple second grooves that the size of bottle is adaptive；The lower section being positioned at described box body inner chamber is provided with drawer, is equipped with micro-in described drawer
Orifice plate；By arranging the first groove and the second groove in the first fixed plate of setting in described box body, reagent bottle vertically embeds
Described first groove or the second groove, not only secure reagent bottle, it is to avoid reagent bottle is sent out with other reagent bottle in described box body
Raw collision, it is ensured that reagent or antibody-solutions in reagent bottle remain intact, and good stability, is vertically to put due to reagent bottle again
Put, be greatly saved the space in described box body so that be compacter inside described test kit, reduce described test kit
Volume, it is simple to the transport of test kit reduces cost, is provided with drawer further through in the lower section being positioned at described box body inner chamber, described in take out
It is equipped with microwell plate in drawer, in order to described microwell plate horizontal positioned, not only ensures fixing described microwell plate, it is to avoid microwell plate exists
Collide with other reagent bottle in described box body, but also be greatly saved the space in described box body so that described examination
Inside agent box compacter, reduce the volume of described test kit, it is simple to the transport of test kit reduces cost, to sum up, this reality
With novel described test kit there is convenient use, simple to operate, good stability, and there is higher detection sensitivity and special
Property, testing result more accurately and reliably, has reached preferably performance parameter；
Carry out detecting PG I He by described double labelling time resolved fluoro-immunoassay test kit based on PG magnetic particle
PGII, owing to the reagent bottle in described test kit is fixing reliable, in transportation, the reagent in reagent bottle, antibody have kept
Good, stability is high, and then can provide a kind of close to homogeneous reaction system, is conducive to the carrying out of detection, is greatly shortened reaction
Time, improve detection sensitivity, greatly reduce pairing antibody consumption and improve precision and the sensitivity of detection, being less than
Serum (slurry) sample of 0.5ng/mL need not dilution, can directly detect, simple to operate, the most also has broad quantum, sample
Concentration value can accurately detect between 0.5-100ng/mL, the detection time is short, and from sample incubation to detection, about 25min completes,
Sample requirements is few, and one time loading only needs 50 μ L.
(2) double labelling time resolved fluoro-immunoassay test kit based on PG magnetic particle described in the utility model, institute
Being provided with the second fixed plate in stating drawer, described second fixed plate is provided with horizontal positioned the 3rd groove of described microwell plate,
By being embedded in described second fixed plate by described microwell plate, described microwell plate can be fixed, it is to avoid described microwell plate is described
Slide in drawer, collide with described inboard wall of cartridge, described microwell plate is caused abrasion.
(3) double labelling time resolved fluoro-immunoassay test kit based on PG magnetic particle described in the utility model is logical
Cross and be provided with handle on the arm-tie of described drawer, it is simple to pull out described drawer, convenient use.
(4) double labelling time resolved fluoro-immunoassay test kit based on PG magnetic particle described in the utility model is logical
Cross described first groove, the second groove successively along the length direction spread configuration of described first fixed plate, reached rational
Utilize the space of described tray interior, be greatly reduced the volume of described box body, it is simple to the transport of described test kit, reduce into
This.
(5) double labelling time resolved fluoro-immunoassay test kit based on PG magnetic particle described in the utility model is logical
Crossing and be respectively equipped with some cooling baths in described first fixed plate and described second fixed plate, described cooling bath is built-in with ice bag,
So that reagent, antibody in reagent bottle in described test kit are maintained under low temperature state, it is simple to preserve, improve reagent,
The stability of antibody.
Accompanying drawing explanation
In order to be illustrated more clearly that the specific embodiment of the invention or technical scheme of the prior art, below will be to specifically
In embodiment or description of the prior art, the required accompanying drawing used is briefly described, it should be apparent that, in describing below
Accompanying drawing is some embodiments of the present invention, for those of ordinary skill in the art, before not paying creative work
Put, it is also possible to obtain other accompanying drawing according to these accompanying drawings.
Fig. 1 is dual-time resolved fluorometric immunoassay based on the PG magnetic particle examination described in this utility model embodiment
Agent box structural representation；
Fig. 2 is dual-time resolved fluorometric immunoassay based on the PG magnetic particle examination described in this utility model embodiment
Agent box structural representation；
Fig. 3 is the first fixed plate structure schematic diagram described in this utility model embodiment；
Fig. 4 is the second fixed plate structure schematic diagram described in this utility model embodiment；
Fig. 5 is the microwell plate structural representation described in this utility model embodiment；
Fig. 6 is the reagent bottle structural representation described in this utility model embodiment；
Fig. 7 is dual-time resolved fluorometric based on the PG magnetic particle immunity described in this utility model another embodiment
Assay kit structural representation；
Fig. 8 is that this utility model implements the dual-time resolved fluorometric based on PG magnetic particle described in another embodiment
Immunoassay kits structural representation.
Description of reference numerals:
1-box body, 2-lid, 3-the first fixed plate, 4-strengthens liquid reagent bottle, 5-concentrated cleaning solutions reagent bottle, and 6-reaction is slow
Rushing liquid reagent bottle, 7-the first groove, 8-is coated the magnetic particle reagent bottle of PG monoclonal antibody, the calibration object reagent bottle of 9-PG, 10-
Europium labelling PG I monoclonal antibody solution reagent bottle, the PGII monoclonal antibody solution reagent bottle of 11-samarium labelling, 12-the second groove, 13-drawer, 14-
Microwell plate, 15-the second fixed plate, 16-the 3rd groove, 17-arm-tie, 18-handle, 19-cooling bath, 20-clamp.
Detailed description of the invention
Below in conjunction with accompanying drawing, technical scheme is clearly and completely described, it is clear that described enforcement
Example is a part of embodiment of the present invention rather than whole embodiments.Based on the embodiment in the present invention, ordinary skill
The every other embodiment that personnel are obtained under not making creative work premise, broadly falls into the scope of protection of the invention.
In describing the invention, it should be noted that term " " center ", " on ", D score, "left", "right", " vertically ",
Orientation or the position relationship of the instruction such as " level ", " interior ", " outward " they are based on orientation shown in the drawings or position relationship, merely to
Be easy to describe the present invention and simplifying describe rather than instruction or the hint device of indication or element must have specific orientation,
With specific azimuth configuration and operation, therefore it is not considered as limiting the invention.Additionally, term " first ", " second ",
" the 3rd " is only used for describing purpose, and it is not intended that indicate or hint relative importance.
In describing the invention, it should be noted that unless otherwise clearly defined and limited, term " is installed ", " phase
Even ", " connection " should be interpreted broadly, for example, it may be fixing connection, it is also possible to be to removably connect, or be integrally connected；Can
To be mechanical connection, it is also possible to be electrical connection；Can be to be joined directly together, it is also possible to be indirectly connected to by intermediary, Ke Yishi
The connection of two element internals.For the ordinary skill in the art, can understand that above-mentioned term is at this with concrete condition
Concrete meaning in invention.
If additionally, the most non-structure of technical characteristic involved in invention described below difference embodiment
Become conflict just can be combined with each other.
As shown in Fig. 1-3, Fig. 5-6, double labelling time-resolved fluorescence based on PG magnetic particle described in the utility model is exempted from
Epidemic disease assay kit, it includes box body 1, be connected with described box body 1 for the lid 2 that described box body 1 is closed, institute
State and bottom box body 1, be provided with the first fixed plate 3, described first fixed plate 3 is provided with and is the most vertically placed with enhancing liquid reagent bottle
4, multiple first grooves 7 that the size of concentrated cleaning solutions reagent bottle 5 and reaction buffer reagent bottle 6 is adaptive, and the most vertically
It is placed with and is coated the magnetic particle reagent bottle 8 of PG monoclonal antibody, the calibration object reagent bottle 9 of PG, europium labelling PG I monoclonal antibody solution reagent
Multiple second grooves 12 that the size of the PGII monoclonal antibody solution reagent bottle 11 of bottle 10 and samarium labelling is adaptive；It is positioned at described box body 1
The lower section in chamber is provided with drawer 13, is equipped with microwell plate 14 in described drawer 13.
By arranging the first groove 7 and the second groove 12, reagent bottle in the first fixed plate 3 of setting in described box body 1
Vertically embed described first groove 7 or the second groove 12, not only secure reagent bottle, it is to avoid reagent bottle described box body 1 in and
Other reagent bottle collide, it is ensured that reagent, antibody in reagent bottle remains intact, stable, are vertically to put due to reagent bottle again
Put, be greatly saved the space in described box body 1 so that compacter inside described test kit, reduce described test kit
Volume, it is simple to the transport of test kit reduces cost, is provided with drawer 13 further through in the lower section being positioned at described box body 1 inner chamber,
It is equipped with microwell plate 14 in described drawer 13, in order to described microwell plate 14 horizontal positioned, not only ensures fixing described microwell plate
14, it is to avoid described microwell plate 14 collides with other reagent bottle in described box body 1, but also is greatly saved described box
Space in body 1 so that compacter inside described test kit, reduces the volume of described test kit, it is simple to the fortune of test kit
Defeated reducing cost, to sum up, test kit described in the utility model has convenient use, simple to operate, good stability, and has
Higher detection sensitivity and specificity, testing result more accurately and reliably, has reached preferably performance parameter.
Further, as shown in Figure 2, Figure 4 shows, the second fixed plate 15, described second fixed plate it are provided with in described drawer 13
15 are provided with horizontal positioned the 3rd groove 16 of described microwell plate 14, fixes by described microwell plate 14 is embedded described second
In plate 15, described microwell plate 14 can be fixed, it is to avoid described microwell plate 14 slides in described drawer 13, and in described box body 1
Wall collides, and described microwell plate 14 causes abrasion, but also is greatly saved the space in described box body 1 so that institute
State inside test kit compacter, reduce the volume of described test kit, it is simple to the transport of test kit reduces cost.
Further, as it is shown in figure 1, be provided with handle 18 on the arm-tie 17 of described drawer 13.By at described drawer 13
Arm-tie 17 on arrange handle 18, can conveniently pull out described drawer 13, described microwell plate 14 is put into described drawer 13,
Convenient use.
Further, the top edge of described arm-tie 17 is connected with described box body 1 by attachment means, can be at described arm-tie
The top edge of 17 arranges magnetic devices, and the correspondence position at described box body 1 arranges the magnetic devices that described magnetic devices matches,
When the magnetic devices that the magnetic devices that the top edge of described arm-tie 17 is arranged is arranged with the correspondence position of described box body 1 contacts,
And then described drawer 13 can be controlled be fixed on described box body 1, it is to avoid in transportation, described drawer 13 skids off, and damages
The medicine and reagent of dress in described drawer 13.Further, as Figure 7-8, the top edge of the arm-tie 17 of described drawer 13 and institute
Stating described box body 1 contour, the top edge of described arm-tie 17 is rotatably connected to clamp 20, and described clamp 20 can be with turn buckle described
On box body 1, described drawer 13 is fixed on described box body 1.By arranging described clamp 20, described drawer 13 can be fixed
On described box body 1, it is to avoid in transportation, described drawer 13 skids off, and damages the medicine and reagent contained in described drawer 13.
Further, as it is shown on figure 3, described first groove the 7, second groove 11 is successively along the length of described first fixed plate 3
Degree direction spread configuration, has reached reasonably to utilize the space of described tray interior, has been greatly reduced the volume of described box 1, just
In the transport of described test kit, reduce cost.
Further, as shown in Figure 3-4, described first fixed plate 3 and described second fixed plate 15 are respectively equipped with some
Cooling bath 19, described cooling bath 19 is built-in with ice bag, so that reagent, antibody in the reagent bottle in described test kit keep
Under low temperature state, it is simple to preserve, improve reagent, the stability of antibody.
Further, described microwell plate 14 is made up of removable ELISA Plate and the enzyme mark strip being placed on it.
Further, described microwell plate 14 is 96 transparent orifice plates.
Further, described microwell plate 14 has Fresco Bag outer package, is additionally provided with inside described Fresco Bag outer package
Desiccant bag.
Obviously, above-described embodiment is only for clearly demonstrating example, and not restriction to embodiment.Right
For those of ordinary skill in the field, can also make on the basis of the above description other multi-form change or
Variation.Here without also cannot all of embodiment be given exhaustive.And the obvious change thus extended out or
Change among still in the protection domain of the invention.
Claims (10)
1. a double labelling time resolved fluoro-immunoassay test kit based on PG magnetic particle, it includes box body (1), with described
Box body (1) be connected for the lid (2) that described box body (1) is closed, it is characterised in that described box body (1) bottom
It is provided with the first fixed plate (3), described first fixed plate (3) is provided with and is the most vertically placed with enhancing liquid reagent bottle (4), concentrate
Multiple first grooves (7) that the size of cleanout fluid reagent bottle (5) and reaction buffer reagent bottle (6) is adaptive, and the most vertically
It is placed with and is coated the magnetic particle reagent bottle (8) of PG monoclonal antibody, the calibration object reagent bottle (9) of PG, europium labelling PG I monoclonal antibody solution
Multiple second grooves (12) that the size of PGII monoclonal antibody solution reagent bottle (11) of reagent bottle (10) and samarium labelling is adaptive；It is positioned at institute
The lower section stating box body (1) inner chamber is provided with drawer (13), is equipped with microwell plate (14) in described drawer (13).
Test kit the most according to claim 1, it is characterised in that described drawer is provided with the second fixed plate in (13)
(15), described second fixed plate (15) is provided with horizontal positioned the 3rd groove (16) of described microwell plate (14).
Test kit the most according to claim 2, it is characterised in that be provided with handle on the arm-tie (17) of described drawer (13)
(18)。
Test kit the most according to claim 3, it is characterised in that the top edge of described arm-tie (17) by attachment means with
Described box body (1) connects.
Test kit the most according to claim 4, it is characterised in that the top edge of the arm-tie (17) of described drawer (13) and institute
Stating box body (1) contour, the top edge of described arm-tie (17) is rotatably connected to clamp (20), and described clamp (20) can exist with turn buckle
On described box body (1), described drawer (13) is fixed on described box body (1).
6. according to the test kit described in any one of claim 1-5, it is characterised in that described first groove (7), the second groove
(12) successively along the length direction spread configuration of described first fixed plate (3).
7. according to the test kit described in any one of claim 2-5, it is characterised in that described first fixed plate (3) and described
Being respectively equipped with some cooling baths (19) in two fixed plates (15), described cooling bath (19) is built-in with ice bag.
8. according to the test kit described in any one of claim 1-5, it is characterised in that described microwell plate (14) is by removable enzyme mark
Plate and the enzyme mark strip composition being placed on it.
Test kit the most according to claim 8, it is characterised in that described microwell plate (14) is 96 transparent orifice plates.
Test kit the most according to claim 9, it is characterised in that described microwell plate (14) has Fresco Bag outer package,
It is additionally provided with desiccant bag inside described Fresco Bag outer package.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201620422755.5U CN205786663U (en) | 2016-05-11 | 2016-05-11 | Double labelling time resolved fluoro-immunoassay test kit based on PG magnetic particle |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201620422755.5U CN205786663U (en) | 2016-05-11 | 2016-05-11 | Double labelling time resolved fluoro-immunoassay test kit based on PG magnetic particle |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN205786663U true CN205786663U (en) | 2016-12-07 |
Family
ID=57409719
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201620422755.5U Active CN205786663U (en) | 2016-05-11 | 2016-05-11 | Double labelling time resolved fluoro-immunoassay test kit based on PG magnetic particle |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN205786663U (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106645671A (en) * | 2017-01-03 | 2017-05-10 | 鲁孝芹 | Clinical examination kit |
-
2016
- 2016-05-11 CN CN201620422755.5U patent/CN205786663U/en active Active
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106645671A (en) * | 2017-01-03 | 2017-05-10 | 鲁孝芹 | Clinical examination kit |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104730247A (en) | Kit suitable for rapidly detecting AMH and INHB by using double-tagging time resolution fluorescence immunoassay method and use method of kit | |
| CN105785016A (en) | Double-tagging time resolution fluoroimmunoassay reagent kit based on PG magnetic particle | |
| JP6749337B2 (en) | Prostate antigen standards and their use | |
| CN107543932A (en) | The magnetic microparticle chemiluminescence detection kit and preparation method of a kind of calcitonin | |
| CN105785043A (en) | Kit for quantitatively detecting AFP-L3% | |
| CN105572353A (en) | Antibody chip reagent kit for detecting hepatoma marker | |
| CN108169486A (en) | A kind of kit and its test method for measuring squamous cell carcinoma-related antigen content | |
| CN107389950A (en) | The detection method and detection kit of identification of human amino-terminal pro-brain natriuretic peptide precursor in a kind of blood | |
| CN108398563A (en) | A kind of double labelling magnetic bead time-resolved fluoroimmunoassay quantitatively detects cTnI and H-FABP kits | |
| CN101377509A (en) | III type precollagen N end peptide chemiluminescence immune analysis quantitative determination reagent kit and preparing method thereof | |
| CN106645756A (en) | Kit for detecting NMP22 (Nuclear Matrix Protein 22) and preparation method thereof | |
| Chan et al. | Time-resolved immunofluorometric assay of alpha-fetoprotein in serum and amniotic fluid, with a novel detection system. | |
| CN205786663U (en) | Double labelling time resolved fluoro-immunoassay test kit based on PG magnetic particle | |
| CN101769931B (en) | Fetus alpha globulin detection particles, preparation thereof and application thereof | |
| CN108226464A (en) | A kind of kit and its test method for measuring thyroglobulin content | |
| CN110988333A (en) | Serum tissue metalloproteinase inhibitor-1 chemiluminescence immunoassay kit and preparation method thereof | |
| CN101344525A (en) | Detection method for AMACR auto-antibody and its application in prostatic cancer diagnosis | |
| CN106645065A (en) | Synthesis method of fluorescent reagent for identifying specificity and sensitively detecting human albumin and application | |
| CN102095847A (en) | Method for detecting content of hyaluronic acid in human serum | |
| CN107167590B (en) | The board-like chemoluminescence method detection kit and preparation method of carbohydrate antigen 242 | |
| CN108333370A (en) | A kind of magnetic bead time-resolved fluoroimmunoassay quantitatively detects cTnI kits | |
| CN106353505B (en) | ApoE kits based on catalyzed signal amplification | |
| CN103116025A (en) | Kit for comprehensive detection of gastric cancer by means of time-resolved fluorescence method and application thereof | |
| CN102818892A (en) | Detection kit for prostate specific antigen and preparation method thereof | |
| CN207472899U (en) | A kind of kit for quantitatively detecting NGAL in urine or blood |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant |